US Patent Family Members and Approved Drugs for Canada Patent: 2258491
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2258491
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2016-07-05 | somatropin | Novo Nordisk Inc. | NORDITROPIN |
| ⤷ Get Started Free | 2016-07-05 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
